These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

165 related articles for article (PubMed ID: 35458727)

  • 21. A self-cascaded unimolecular prodrug for pH-responsive chemotherapy and tumor-detained photodynamic-immunotherapy of triple-negative breast cancer.
    Yao D; Wang Y; Bian K; Zhang B; Wang D
    Biomaterials; 2023 Jan; 292():121920. PubMed ID: 36442436
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Photo-responsive hollow silica nanoparticles for light-triggered genetic and photodynamic synergistic therapy.
    Lin X; Wu M; Li M; Cai Z; Sun H; Tan X; Li J; Zeng Y; Liu X; Liu J
    Acta Biomater; 2018 Aug; 76():178-192. PubMed ID: 30078423
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Far-Red Light-Activatable Prodrug of Paclitaxel for the Combined Effects of Photodynamic Therapy and Site-Specific Paclitaxel Chemotherapy.
    Thapa P; Li M; Bio M; Rajaputra P; Nkepang G; Sun Y; Woo S; You Y
    J Med Chem; 2016 Apr; 59(7):3204-14. PubMed ID: 26974508
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Light-triggered dual-modality drug release of self-assembled prodrug-nanoparticles for synergistic photodynamic and hypoxia-activated therapy.
    Zhao D; Tao W; Li S; Li L; Sun Y; Li G; Wang G; Wang Y; Lin B; Luo C; Wang Y; Cheng M; He Z; Sun J
    Nanoscale Horiz; 2020 May; 5(5):886-894. PubMed ID: 32219262
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Binary dimeric prodrug nanoparticles for self-boosted drug release and synergistic chemo-photodynamic therapy.
    Zhang Y; Pei Q; Yue Y; Xie Z
    J Mater Chem B; 2022 Feb; 10(6):880-886. PubMed ID: 35043826
    [TBL] [Abstract][Full Text] [Related]  

  • 26. ROS-triggered cycle amplification effect: A prodrug activation nanoamplifier for tumor-specific therapy.
    Huang Z; Ding Y; Luo Y; Chen M; Zeng Z; Zhang T; Sun Y; Huang Y; Zhao C
    Acta Biomater; 2022 Oct; 152():367-379. PubMed ID: 36084924
    [TBL] [Abstract][Full Text] [Related]  

  • 27. pH-sensitive prodrug conjugated polydopamine for NIR-triggered synergistic chemo-photothermal therapy.
    Zhang H; Sun Y; Huang R; Cang H; Cai Z; Sun B
    Eur J Pharm Biopharm; 2018 Jul; 128():260-271. PubMed ID: 29733952
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Design of light/ROS cascade-responsive tumor-recognizing nanotheranostics for spatiotemporally controlled drug release in locoregional photo-chemotherapy.
    Zuo W; Chen D; Fan Z; Chen L; Zhu Z; Zhu Q; Zhu X
    Acta Biomater; 2020 Jul; 111():327-340. PubMed ID: 32434075
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Tumor-Penetrating Nanoparticles for Enhanced Anticancer Activity of Combined Photodynamic and Hypoxia-Activated Therapy.
    Wang Y; Xie Y; Li J; Peng ZH; Sheinin Y; Zhou J; Oupický D
    ACS Nano; 2017 Feb; 11(2):2227-2238. PubMed ID: 28165223
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Therapeutic efficacy, pharmacokinetic profiles, and toxicological activities of humanized antibody-drug conjugate Zt/g4-MMAE targeting RON receptor tyrosine kinase for cancer therapy.
    Yao HP; Feng L; Suthe SR; Chen LH; Weng TH; Hu CY; Jun ES; Wu ZG; Wang WL; Kim SC; Tong XM; Wang MH
    J Immunother Cancer; 2019 Mar; 7(1):75. PubMed ID: 30871619
    [TBL] [Abstract][Full Text] [Related]  

  • 31. An upconversion nanoplatform for simultaneous photodynamic therapy and Pt chemotherapy to combat cisplatin resistance.
    Ai F; Sun T; Xu Z; Wang Z; Kong W; To MW; Wang F; Zhu G
    Dalton Trans; 2016 Aug; 45(33):13052-60. PubMed ID: 27430044
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Photosensitizer-driven nanoassemblies of homodimeric prodrug for self-enhancing activation and synergistic chemo-photodynamic therapy.
    Zhang S; Wang Z; Kong Z; Wang Y; Zhang X; Sun B; Zhang H; Kan Q; He Z; Luo C; Sun J
    Theranostics; 2021; 11(12):6019-6032. PubMed ID: 33897896
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Bone-Targeting Prodrug Mesoporous Silica-Based Nanoreactor with Reactive Oxygen Species Burst for Enhanced Chemotherapy.
    Tong F; Ye Y; Chen B; Gao J; Liu L; Ou J; van Hest JCM; Liu S; Peng F; Tu Y
    ACS Appl Mater Interfaces; 2020 Aug; 12(31):34630-34642. PubMed ID: 32635715
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Highly Stable Silica-Coated Bismuth Nanoparticles Deliver Tumor Microenvironment-Responsive Prodrugs to Enhance Tumor-Specific Photoradiotherapy.
    Xiang H; Wu Y; Zhu X; She M; An Q; Zhou R; Xu P; Zhao F; Yan L; Zhao Y
    J Am Chem Soc; 2021 Aug; 143(30):11449-11461. PubMed ID: 34292717
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Photo-responsive prodrug nanoparticles for efficient cytoplasmic delivery and synergistic photodynamic-chemotherapy of metastatic triple-negative breast cancer.
    Jiao J; Lu H; Wang S
    Acta Biomater; 2021 May; 126():421-432. PubMed ID: 33774201
    [TBL] [Abstract][Full Text] [Related]  

  • 36. ROS-Responsive Selenium-Containing Carriers for Coencapsulation of Photosensitizer and Hypoxia-Activated Prodrug and Their Cellular Behaviors.
    Song F; Li S; Sun C; Ji Y; Zhang Y
    Macromol Biosci; 2021 Dec; 21(12):e2100229. PubMed ID: 34390189
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Co-Delivery of Cisplatin Prodrug and Chlorin e6 by Mesoporous Silica Nanoparticles for Chemo-Photodynamic Combination Therapy to Combat Drug Resistance.
    Zhang W; Shen J; Su H; Mu G; Sun JH; Tan CP; Liang XJ; Ji LN; Mao ZW
    ACS Appl Mater Interfaces; 2016 Jun; 8(21):13332-40. PubMed ID: 27164222
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Targeting cell surface alpha(v)beta(3) integrin increases therapeutic efficacies of a legumain protease-activated auristatin prodrug.
    Liu Y; Bajjuri KM; Liu C; Sinha SC
    Mol Pharm; 2012 Jan; 9(1):168-75. PubMed ID: 22044266
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Arylboronate prodrugs of doxorubicin as promising chemotherapy for pancreatic cancer.
    Skarbek C; Serra S; Maslah H; Rascol E; Labruère R
    Bioorg Chem; 2019 Oct; 91():103158. PubMed ID: 31376782
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Combination of cancer-specific prodrug nanoparticle with Bcl-2 inhibitor to overcome acquired drug resistance.
    Kim J; Shim MK; Yang S; Moon Y; Song S; Choi J; Kim J; Kim K
    J Control Release; 2021 Feb; 330():920-932. PubMed ID: 33152391
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.